Diabetes | 2021

Efficacy and safety of 28‐day treatment with oral insulin (ORMD‐0801) in patients with type 2 diabetes: A randomized, placebo‐controlled trial

 
 
 
 

Abstract

To assess the safety and efficacy of oral insulin (ORMD‐0801) in patients with type 2 diabetes (T2D).

Volume 23
Pages 2529 - 2538
DOI 10.1111/dom.14499
Language English
Journal Diabetes

Full Text